Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer

Trastuzumab is a milestone in the treatment of human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC), in both the early and metastatic settings. Over the last two decades, clinical trials have established the good safety profile of trastuzumab. Cardiotoxicity remains the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzotta, Marco, Krasniqi, Eriseld, Barchiesi, Giacomo, Pizzuti, Laura, Tomao, Federica, Barba, Maddalena, Vici, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406268/
https://www.ncbi.nlm.nih.gov/pubmed/30781624
http://dx.doi.org/10.3390/jcm8020254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406268/
https://www.ncbi.nlm.nih.gov/pubmed/30781624
http://dx.doi.org/10.3390/jcm8020254

Ejemplares similares